PAPD4 (TENT2) (NM_173797) Human Tagged ORF Clone Lentiviral Particle
CAT#: RC203610L4V
- LentiORF®
-
Lenti ORF particles, PAPD4 (mGFP-tagged) - Human PAP associated domain containing 4 (PAPD4), transcript variant 3, 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 10,450.00
货期*
详询
规格
Product images
![](https://cdn.origene.com/img/defaults-img.jpg)
经常一起买 (3)
Specifications
Product Data | |
Product Name | PAPD4 (TENT2) (NM_173797) Human Tagged ORF Clone Lentiviral Particle |
Synonyms | APD4; GLD2; PAPD4; TUT2 |
Vector | pLenti-C-mGFP-P2A-Puro |
ACCN | NM_173797 |
ORF Size | 1452 bp |
Sequence Data |
The ORF insert of this clone is exactly the same as(RC203610).
|
OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
Reference Data | |
RefSeq | NM_173797.2 |
RefSeq Size | 3282 bp |
RefSeq ORF | 1455 bp |
Locus ID | 167153 |
MW | 56 kDa |
Gene Summary | Cytoplasmic poly(A) RNA polymerase that adds successive AMP monomers to the 3'-end of specific RNAs, forming a poly(A) tail. In contrast to the canonical nuclear poly(A) RNA polymerase, it only adds poly(A) to selected cytoplasmic mRNAs (PubMed:15070731). Does not play a role in replication-dependent histone mRNA degradation (PubMed:18172165). Adds a single nucleotide to the 3' end of specific miRNAs, monoadenylation stabilizes and prolongs the activity of some but not all miRNAs (PubMed:23200856).[UniProtKB/Swiss-Prot Function] |
Documents
Product Manuals |
FAQs |
SDS |
Resources
You may also need
Customer
Reviews
Loading...